20/20 Biolabs, Inc. Common Stock (AIDX) compared with its closest peers (BNBX, ISPC, VNRX, QCLS, ABSI). Peer set by Business Services; 10 comparable business services companies. First-party data.
BNB Plus shares 20/20 Biolabs, Inc. Common Stock's sub-industry, testing laboratories.
| Company | Market Cap | P/E |
|---|---|---|
| BNB Plus Corp. (BNBX) | $1.08M | — |
| iSpecimen Inc. (ISPC) | $3.78M | -0.1 |
| VolitionRx Limited (VNRX) | $3.15M | — |
| Q/C Technologies, Inc. (QCLS) | $15.68M | -0.5 |
| Absci Corporation (ABSI) | $1.37B | -4.1 |
| OneMedNet Corporation (ONMD) | — | — |
| Insight Molecular Diagnostics Inc. (IMDX) | $131.55M | -4.5 |
| Biomerica, Inc. (BMRA) | $10.05M | -1.4 |
| bioAffinity Technologies, Inc. (BIAF) | $4.28M | -0.1 |
| OmniAb, Inc. (OABI) | $731.31M | -3.2 |
| Sector P/E (Technology) | 31.8 |
| Industry P/E (Business Services) | 28.3 |
AIDX overview · AIDX earnings · AIDX financials · AIDX KPIs · AIDX documents · AIDX ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.